Good Blood Analytics Swiss proudly pronounces the attainment of EU-MDR certification for his or her VIRUS vs. BACTERIA Medical Resolution Assist Software program.
ZURICH, SWITZERLAND, April 22, 2024 /EINPresswire.com/ — In a major stride in direction of stopping antimicrobial resistance, Good Blood Analytics Swiss proudly pronounces the attainment of EU-MDR (European Medical Gadget Regulation) certification(1) for his or her VIRUS vs. BACTERIA Medical Resolution Assist Software program. This modern medical system units a brand new benchmark in precisely distinguishing between viral and bacterial infections, thus aiding physicians in delivering focused and efficient therapy to sufferers.
Antimicrobial resistance (AMR) poses a major menace to international public well being and growth, contributing to thousands and thousands of deaths yearly. Primarily pushed by the misuse and overuse of antibiotics, AMR undermines the effectiveness of remedies for infectious illnesses, placing trendy medical developments in danger and rising healthcare prices considerably. The World Well being Group (WHO) emphasizes stopping infections, guaranteeing common entry to high quality prognosis and therapy, and selling innovation in surveillance and analysis to deal with antimicrobial resistance in human well being(2).
As the primary Medical Resolution Assist Software program to obtain EU-MDR certification within the area of infectious illness administration, VIRUS vs. BACTERIA makes use of solely 17 routine blood parameters, organic intercourse, and age to tell apart between viral and bacterial infections. The VIRUS vs. BACTERIA mannequin has additionally lately been showcased in an article printed in Heliyon, highlighting its effectiveness and nice accuracy (https://doi.org/10.1016/j.heliyon.2024.e29372).
With routine blood testing being available worldwide, VIRUS vs. BACTERIA tremendously expands the physician’s capability to distinguish between viral and bacterial infections and aids within the rational use of antibiotics, particularly within the vary the place different generally used blood markers supply restricted diagnostic worth.
The thought to develop VIRUS vs. BACTERIA was impressed by the 2022 G20 Bali summit, the place a Name to Motion on antimicrobial resistance was introduced(3). It emphasised the pressing want for modern options to fight the rising worldwide menace of AMR, also known as the silent pandemic. This occasion convened international leaders to deal with the challenges, and it highlighted the significance of collaborative efforts to develop efficient methods for an infection administration.
Dr. Marko Notar, CEO of Good Blood Analytics Swiss, shared his pleasure concerning the EU-MDR certification, stating, “This achievement exhibits our dedication to advancing healthcare by way of innovation. By offering clinicians with a exact device to distinguish between viral and bacterial infections, we goal to empower medical doctors with extra info and assist them of their choice of antibiotic prescriptions. This contributes to simpler healthcare practices.”
The EU-MDR certification course of entails an intensive and intensive analysis of medical system security, high quality, and compliance with European Union rules governing medical units. Good Blood Analytics Swiss is dedicated to sustaining the best requirements of security, efficiency, and compliance, and this EU-MDR certification reaffirms its ongoing dedication to excellence within the healthcare trade.
In an period the place healthcare challenges demand modern options, VIRUS vs. BACTERIA emerges as an answer of nice promise. Being accessible to make use of worldwide and with its user-friendly interface and highly effective capabilities, this cutting-edge device stands able to empower healthcare professionals of their battle towards antimicrobial resistance.
About Good Blood Analytics Swiss:
Good Blood Analytics Swiss is a forward-thinking healthcare know-how firm devoted to remodeling the medical diagnostic course of. Their flagship product, SBAS Software program, employs synthetic intelligence to boost the accuracy and effectivity of the interpretation of blood take a look at outcomes. With a dedication to excellence and a deal with affected person well-being, Good Blood Analytics Swiss is on the forefront of innovation in healthcare, repeatedly growing new merchandise within the area of blood take a look at end result interpretation. This contains pioneering options that present a deeper dive into understanding and recommending which blood parameters contribute to the selections that decide the precise prognosis for the affected person.
For extra info on how Good Blood Analytics Swiss might help rework the medical diagnostic course of, go to: www.smartbloodanalytics.com.
1. Regulation (EU) 2017/745 on Medical Units
2. https://www.who.int/news-room/fact-sheets/element/antimicrobial-resistance
3. https://www.g20.org/en
Manca Köster
Good Blood Analytics Swiss
manca@sba-swiss.com
Go to us on social media:
LinkedIn
YouTube